CC
ZBH icon

ClearArc Capital’s Zimmer Biomet ZBH Stock Holding History

ClearArc Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$329K Sell
2,261
-914
-29% -$126K 0.13% 192
2019
Q3 		$423K Buy
3,175
+12
+0.4% +$1.55K 0.12% 202
2019
Q2 		$362K Sell
3,163
-354
-10% -$41.5K 0.11% 225
2019
Q1 		$436K Sell
3,517
-89
-2% -$10.1K 0.12% 199
2018
Q4 		$363K Sell
3,606
-1,795
-33% -$202K 0.11% 217
2018
Q3 		$689K Buy
5,401
+52
+1% +$6.18K 0.09% 213
2018
Q2 		$579K Sell
5,349
-6
-0.1% -$653 0.08% 236
2018
Q1 		$567K Buy
5,355
+70
+1% +$8.13K 0.09% 241
2017
Q4 		$619K Sell
5,285
-89
-2% -$10.1K 0.08% 234
2017
Q3 		$611K Buy
5,374
+270
+5% +$31.2K 0.09% 231
2017
Q2 		$636K Buy
5,104
+60
+1% +$7.11K 0.1% 209
2017
Q1 		$598K Buy
5,044
+26
+0.5% +$2.95K 0.1% 219
2016
Q4 		$503K Sell
5,018
-41
-0.8% -$4.39K 0.09% 236
2016
Q3 		$639K Buy
5,059
+555
+12% +$68.6K 0.12% 189
2016
Q2 		$526K Sell
4,504
-6
-0.1% -$679 0.1% 219
2016
Q1 		$467K Buy
4,510
+184
+4% +$17.8K 0.1% 239
2015
Q4 		$431K Buy
4,326
+73
+2% +$7.14K 0.09% 259
2015
Q3 		$388K Sell
4,253
-93
-2% -$9.32K 0.08% 284
2015
Q2 		$461K Buy
4,346
+545
+14% +$60.3K 0.08% 268
2015
Q1 		$434K Buy
3,801
+71
+2% +$8.1K 0.09% 266
2014
Q4 		$411K Buy
3,730
+121
+3% +$12.8K 0.08% 270
2014
Q3 		$352K Buy
3,609
+147
+4% +$14.5K 0.08% 271
2014
Q2 		$349K Sell
3,462
-464
-12% -$45.3K 0.08% 271
2014
Q1 		$361K Buy
3,926
+2
+0.1% +$184 0.09% 259
2013
Q4 		$355K Buy
3,924
+153
+4% +$13.2K 0.09% 244
2013
Q3 		$301K Sell
3,771
-113
-3% -$8.89K 0.08% 266
2013
Q2 		$283K Buy
+3,884
New +$290K 0.08% 291

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

ClearArc Capital's ZBH Position: Q4 2019 in Review

ClearArc Capital reduced its Zimmer Biomet (ZBH) stake by 29% in Q4 2019, selling an estimated $126K and leaving 2,261 shares worth $329K. The position accounts for 0.13% of the portfolio, ranked #192.

ClearArc Capital first reported a position in ZBH in Q2 2013 and has held it in 27 quarters since. The position peaked at $689K in Q3 2018. 990 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • ClearArc Capital held 2,261 shares of Zimmer Biomet worth $329K as of Q4 2019.
  • ClearArc Capital sold 914 Zimmer Biomet shares in Q4 2019, an estimated $126K.
  • Zimmer Biomet made up 0.13% of ClearArc Capital's portfolio in Q4 2019, its #192 holding.
  • ClearArc Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Zimmer Biomet position peaked at $689K in Q3 2018.
  • 990 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.